FMC Corp. has agreed to sell its Peroxygens business to One Equity Partners, the private investment arm of J.P. Morgan Chase & Co., for approximately $200 million. The transaction is expected to close in the first quarter of 2014. Citi advised FMC on the transaction while Macquarie Capital was the sole lead arranger on the financing for the deal.
PHILADELPHIA, Dec. 13, 2013 /PRNewswire/ — FMC Corporation (NYSE: FMC) has signed a definitive agreement to sell its Peroxygens business to affiliates of One Equity Partners, the private investment arm of J.P. Morgan Chase & Co. The transaction, valued at approximately $200 million, is expected to close in the first quarter of 2014, subject to customary regulatory approvals and closing conditions.
In April, FMC simplified its organizational structure to focus on three core business segments that better reflect the markets where the company participates and leads, and where it expects to grow in the future. FMC Peroxygens, although a successful business, is not a strategic fit with the company’s growth platforms.
“We’re pleased to sell our Peroxygens business to a successful and respected investment firm, One Equity Partners,” said Pierre Brondeau, president, CEO and chairman of FMC. “This transaction will help unlock the growth potential of the Peroxygens business with focused attention and investment, while allowing FMC to direct our resources to core segments in crop protection, health and nutrition technologies, alkali chemicals and lithium.”
Citi was FMC’s financial advisor for this transaction.
Macquarie Capital is serving as Sole Lead Arranger on the financing for the transaction.
FMC Corporation is a diversified chemical company serving agricultural, industrial, environmental, and consumer markets globally for more than a century with innovative solutions, applications and quality products. In 2012, FMC had annual sales of approximately $3.4 billion. The company employs approximately 6,000 people throughout the world, and operates its businesses in three segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Minerals. For more information, visit www.FMC.com.
About One Equity Partners
One Equity Partners is the private investment arm of JPMorgan Chase & Co. and manages approximately $14 billion in commitments and investments solely for the bank. OEP enters into long-term partnerships with companies to create sustainable value through long-term growth driven both organically and inorganically. Founded in 2001, OEP has 39 investment professionals in New York, Chicago, Frankfurt, Vienna, Hong Kong, Sao Paulo and elsewhere around the globe. Visit www.oneequity.com for more information.